메뉴 건너뛰기




Volumn 2012, Issue , 2012, Pages

Analysis of quality of nuchal translucency measurements: Its role in prenatal diagnosis

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; ARTICLE; CERTIFICATION; CROWN RUMP LENGTH; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INFANT; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANT WOMAN; QUALITY CONTROL PROCEDURES; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SCREENING; TRISOMY 21; ADOLESCENT; FETUS ECHOGRAPHY; HEALTH CARE QUALITY; MIDDLE AGED; PERINATOLOGY; PREGNANCY; PRENATAL DIAGNOSIS; STANDARD;

EID: 84861022136     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/482832     Document Type: Article
Times cited : (10)

References (26)
  • 1
    • 77950053727 scopus 로고    scopus 로고
    • Impact of quality of nuchal translucency measurements on detection rates of trisomies 13 and 18
    • Evans M. I., Pergament E., Impact of quality of nuchal translucency measurements on detection rates of trisomies 13 and 18 Fetal Diagnosis and Therapy 2010 27 2 68 71
    • (2010) Fetal Diagnosis and Therapy , vol.27 , Issue.2 , pp. 68-71
    • Evans, M.I.1    Pergament, E.2
  • 2
    • 0023713653 scopus 로고
    • Wide variation in maternal serum alpha-fetoprotein reports in one metropolitan area: Concerns for the quality of prenatal testing
    • Evans M. I., Belsky R., Greb A., Dvorin E., Drugan A., Wide variation in maternal serum alpha-fetoprotein reports in one metropolitan area: concerns for the quality of prenatal testing Obstetrics and Gynecology 1988 72 3 I 342 345
    • (1988) Obstetrics and Gynecology , vol.72 , Issue.3 , pp. 342-345
    • Evans, M.I.1    Belsky, R.2    Greb, A.3    Dvorin, E.4    Drugan, A.5
  • 3
    • 0038786849 scopus 로고    scopus 로고
    • Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndrome
    • Knight G. J., Palomaki G. E., Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndrome Clinics in Laboratory Medicine 2003 23 2 531 551
    • (2003) Clinics in Laboratory Medicine , vol.23 , Issue.2 , pp. 531-551
    • Knight, G.J.1    Palomaki, G.E.2
  • 12
    • 75649104945 scopus 로고    scopus 로고
    • Increased nuchal translucency in euploid fetuseswhat should we be telling the parents?
    • Bilardo C. M., Timmerman E., Pajkrt E., Van Maarle M., Increased nuchal translucency in euploid fetuseswhat should we be telling the parents? Prenatal Diagnosis 2010 30 2 93 102
    • (2010) Prenatal Diagnosis , vol.30 , Issue.2 , pp. 93-102
    • Bilardo, C.M.1    Timmerman, E.2    Pajkrt, E.3    Van Maarle, M.4
  • 13
    • 81155160840 scopus 로고    scopus 로고
    • Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype
    • Leung T. Y., Vogel I., Lau T. K., Chong W., Hyett J. A., Petersen O. B., Choy K. W., Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype Ultrasound in Obstetrics and Gynecology 2011 38 3 314 319
    • (2011) Ultrasound in Obstetrics and Gynecology , vol.38 , Issue.3 , pp. 314-319
    • Leung, T.Y.1    Vogel, I.2    Lau, T.K.3    Chong, W.4    Hyett, J.A.5    Petersen, O.B.6    Choy, K.W.7
  • 15
    • 35548978491 scopus 로고    scopus 로고
    • Nuchal translucency measurements for first-trimester screening: The price#8221; Of inaccuracy
    • Evans M. I., Van Decruyes H., Nicolaides K. H., Nuchal translucency measurements for first-trimester screening: the price#8221; of inaccuracy Fetal Diagnosis and Therapy 2007 22 6 401 404
    • (2007) Fetal Diagnosis and Therapy , vol.22 , Issue.6 , pp. 401-404
    • Evans, M.I.1    Van Decruyes, H.2    Nicolaides, K.H.3
  • 18
    • 70349664569 scopus 로고    scopus 로고
    • Technical standards and guidelines: Prenatal screening for down syndrome that includes first-trimester biochemistry and/or ultrasound measurements
    • Palomaki G. E., Lee J. E., Canick J. A., McDowell G. A., Donnenfeld A. E., Technical standards and guidelines: prenatal screening for down syndrome that includes first-trimester biochemistry and/or ultrasound measurements Genetics in Medicine 2009 11 9 669 681
    • (2009) Genetics in Medicine , vol.11 , Issue.9 , pp. 669-681
    • Palomaki, G.E.1    Lee, J.E.2    Canick, J.A.3    McDowell, G.A.4    Donnenfeld, A.E.5
  • 22
    • 0032146382 scopus 로고    scopus 로고
    • UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 1014 weeks of gestation
    • Snijders R. J., Noble P., Sebire N., Souka A., Nicolaides K. H., UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 1014 weeks of gestation The Lancet 1998 352 9125 343 346
    • (1998) The Lancet , vol.352 , Issue.9125 , pp. 343-346
    • Snijders, R.J.1    Noble, P.2    Sebire, N.3    Souka, A.4    Nicolaides, K.H.5
  • 26
    • 0029792138 scopus 로고    scopus 로고
    • Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice
    • Kornman L. H., Morssink L. P., Beekhuis J. R., De Wolf B. T. H. M., Heringa M. P., Mantingh A., Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice Prenatal Diagnosis 1996 16 9 797 805
    • (1996) Prenatal Diagnosis , vol.16 , Issue.9 , pp. 797-805
    • Kornman, L.H.1    Morssink, L.P.2    Beekhuis, J.R.3    De Wolf, B.T.H.M.4    Heringa, M.P.5    Mantingh, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.